These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28830009)

  • 21. Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype.
    Li F; Glinskii OV; Mooney BP; Rittenhouse-Olson K; Pienta KJ; Glinsky VV
    Oncotarget; 2017 Nov; 8(58):98598-98608. PubMed ID: 29228713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural insights into the recognition mechanism between an antitumor galectin AAL and the Thomsen-Friedenreich antigen.
    Feng L; Sun H; Zhang Y; Li DF; Wang DC
    FASEB J; 2010 Oct; 24(10):3861-8. PubMed ID: 20530247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of human tumor associated Thomsen-Friedenreich antigen.
    Samuel J; Noujaim AA; MacLean GD; Suresh MR; Longenecker BM
    Cancer Res; 1990 Aug; 50(15):4801-8. PubMed ID: 2196117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen.
    Karsten U; Butschak G; Cao Y; Goletz S; Hanisch FG
    Hybridoma; 1995 Feb; 14(1):37-44. PubMed ID: 7539400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A tandem enzymatic approach for detecting and imaging tumor-associated Thomsen-Friedenreich antigen disaccharide.
    Li Q; Li Z; Duan X; Yi W
    J Am Chem Soc; 2014 Sep; 136(36):12536-9. PubMed ID: 25157422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1).
    Chung YC; Kuo JF; Wei WC; Chang KJ; Chao WT
    PLoS One; 2015; 10(7):e0133072. PubMed ID: 26172389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
    Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
    Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
    Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
    Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
    Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
    BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Thomsen-Friedenreich antigen on human urothelial cell lines detectable by peanut lectin and monoclonal antibody raised against human glycophorin A.
    Radzikowski CZ; Steuden I; Wiedlocha A; Kieler J; Tromholt V
    Anticancer Res; 1989; 9(1):103-7. PubMed ID: 2650614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma.
    Zhang X; Li Q; Zhao H; Ma L; Meng T; Qian J; Jin R; Shen J; Yu K
    Oncotarget; 2017 Aug; 8(35):59086-59102. PubMed ID: 28938620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts.
    Boghaert ER; Sridharan L; Armellino DC; Khandke KM; DiJoseph JF; Kunz A; Dougher MM; Jiang F; Kalyandrug LB; Hamann PR; Frost P; Damle NK
    Clin Cancer Res; 2004 Jul; 10(13):4538-49. PubMed ID: 15240546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the epitope of a monoclonal antibody that disrupts binding of human transferrin to the human transferrin receptor.
    Teh EM; Hewitt J; Ung KC; Griffiths TA; Nguyen V; Briggs SK; Mason AB; MacGillivray RT
    FEBS J; 2005 Dec; 272(24):6344-53. PubMed ID: 16336271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.
    Graves SS; Goshorn SC; Stone DM; Axworthy DB; Reno JM; Bottino B; Searle S; Henry A; Pedersen J; Rees AR; Libby RT
    Clin Cancer Res; 1999 Apr; 5(4):899-908. PubMed ID: 10213227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design.
    Sun F; Wang T; Jiang J; Wang Y; Ma Z; Li Z; Han Y; Pan M; Cai J; Wang M; Zhang J
    Oncotarget; 2017 Aug; 8(31):51238-51252. PubMed ID: 28881644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
    Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
    Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
    Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
    J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen.
    Hanisch FG; Baldus SE
    Histol Histopathol; 1997 Jan; 12(1):263-81. PubMed ID: 9046061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.